Modifications to a type of immune cell programmed to recognize and kill cancerous tumors could make them even more effective assassins.
Researchers from the Massachusetts Institute of Technology (MIT) and Harvard Medical School have found a…

Modifications to a type of immune cell programmed to recognize and kill cancerous tumors could make them even more effective assassins.
Researchers from the Massachusetts Institute of Technology (MIT) and Harvard Medical School have found a…

Turns out, it’s not the slippery slope of the bathroom you have to be worried about!When we think of urinary tract infections (UTIs), bathroom hygiene is what typically comes to mind. But recent research is pointing in an entirely different…

Many risk factors tied to breast cancer are beyond the control of patients, including genetic factors.
But patients can reduce their risks by taking control of some factors, including maintaining a healthy weight.
Researchers say obesity is one of…

For years, eggs have been caught in the crossfire of dietary debates – blamed for raising cholesterol, linked to heart disease, and often stripped of their yolks in the name of “healthy eating.” But modern research and expert insights…

Using targeted radiation during surgery – referred to as intraoperative radiation – to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins have been able to reduce the…

Hong Kong grave sweepers at a major cemetery have taken preventive measures to protect themselves from mosquito bites, but remain determined to pay respects to their ancestors on Chung Yeung Festival despite visiting an area near the city’s…

Diabetic foot ulcers (DFU) are one of the most common and severe complications in diabetic patients, with an increasing incidence rate. Globally, the prevalence of DFU represents a significant burden. According to the most recent…

New real-world data support the safety and efficacy of zanubrutinib (Brukinsa; BeOne) in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL), regardless of whether they have previously been treated with ibrutinib…
